SKylaRk: Phase II study of Isa-KRD in newly diagnosed, transplant-eligible multiple myeloma
Noopur Raje • 11 Dec 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter